XML 66 R50.htm IDEA: XBRL DOCUMENT v3.22.1
Capital Structure (Details) - USD ($)
 1 Months Ended 12 Months Ended
Sep. 30, 2018
Jun. 30, 2016
Dec. 31, 2021
Capital Structure (Details) [Line Items]      
Valuation expenses (in Dollars)     $ 407,494
Weighted average grant date fair value (in Dollars per share)     $ 0.85
Warrant convertible into common stock     116,903
Warrant [Member]      
Capital Structure (Details) [Line Items]      
Warrants exercisable for shares of common stock 5,750,000   1,055,184
Warrant exercise price (in Dollars per share) $ 1.25   $ 1.25
Description of warrants expiration The warrants were immediately exercisable and expire five years from the date of issuance.   The warrants are exercisable at $1.25 per share of common stock and expire on September 28, 2023.
Issuance of warrants     40,000
Valuation expenses (in Dollars)     $ 522,808
Weighted average grant date fair value (in Dollars per share)     $ 1.63
Preferred Stock [Member]      
Capital Structure (Details) [Line Items]      
Preferred stock, shares authorized     500,000
Preferred stock, par value (in Dollars per share)     $ 0.001
Common Stock [Member]      
Capital Structure (Details) [Line Items]      
Common stock price (in Dollars per share)     $ 23
Convertible preferred stock, terms of conversion, description     The Company is authorized to issue 40,000,000 shares of common stock, par value $0.0001 per share. Each share of common stock entitles the holder to one vote at all stockholder meetings.
Common stock, share authorized     40,000,000
Common stock par or stated per share value (in Dollars per share)     $ 0.0001
Consulting Agreement [Member]      
Capital Structure (Details) [Line Items]      
Warrant exercise price (in Dollars per share)     $ 1.6
Warrants expiration period     4 years
Consulting Agreement [Member] | Warrant [Member]      
Capital Structure (Details) [Line Items]      
Warrant exercise price (in Dollars per share)     $ 1.25
Description of warrants expiration     The warrants are immediately exercisable and expire following the close of business on June 30, 2023.
Warrant, description     As part of a consulting agreement with XLR8 Capital Partners LLC (the “Consulting Agreement”), an entity of which the Company’s Chairman is manager, the Company agreed to issue 40,000 warrants to XLR8 Capital Partners LLC monthly for 12 months beginning on March 1, 2019 at an exercise price of $1.25 per share or, if the closing share price on the last day of the month exceeds $1.25, then such exercise price will be 110% of the closing share price.
Series 1 Convertible Preferred Stock [Member]      
Capital Structure (Details) [Line Items]      
Preferred stock conversion basis, description     As of December 31, 2021, each share of Series 1 Convertible Preferred Stock was convertible into 1.32230 shares of the Company’s common stock, subject to certain anti-dilution rights.
Convertible preferred stock, terms of conversion, description     As of December 31, 2021, there were 170,332 shares of Series 1 Convertible Preferred Stock outstanding, which were convertible into 225,231 shares of common stock. 
Series 1 Convertible Preferred Stock [Member] | Preferred Stock [Member]      
Capital Structure (Details) [Line Items]      
Preferred stock, shares authorized     250,000
Series 2 Convertible Preferred Stock [Member]      
Capital Structure (Details) [Line Items]      
Preferred stock, designated     25,000
Convertible preferred stock, shares issued upon conversion     20,000
Proceeds from sale of stock (in Dollars)     $ 20,000,000
Additional sale of shares     1,952
Gross proceeds (in Dollars)     $ 1,950,000
Preferred shares sold per share (in Dollars per share)     $ 1,000
Stated value, percentage     10.00%
Cumulative accrued dividends (in Dollars)     $ 13,271,173
Preferred stock conversion into common stock, shares     266
Description of warrants expiration   In connection with the issuance of Series 2 Convertible Preferred Stock in June 2016, the Company issued to the placement agent in such offering warrants exercisable for 439 shares of Series 2 Convertible Preferred Stock at an initial exercise price of $1,250 per share, which expire seven years after the date of issuance.